Additionally, FGFR1 signaling can recruit immunosuppressive cells, such as regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), further promoting an immune-permissive environment that protects the tumor from immune attack [28, 29]. The gene discussed is FGFR1; the disease is neoplasm.